Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
REGN Stock Earnings: Regeneron Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
May 02, 2024
Tickers
REGN
Tags
REGN
NASDAQ:REGN
Earnings Reports
From
InvestorPlace
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
May 02, 2024
Tickers
NEWS
REGN
Tags
REGN
News
Trading Ideas
From
Benzinga
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
May 02, 2024
Tickers
CRSP
REGN
SNY
Tags
CRSP
Market News
Recent Press Releases
From
Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
April 30, 2024
Tickers
ISRG
LLY
PFE
REGN
Tags
ZTS
SYK
VKTX
From
Benzinga
Behind the Scenes of Regeneron Pharmaceuticals's Latest Options Trends
April 30, 2024
Tickers
REGN
Tags
BZI/UOA
REGN
Market News
From
Benzinga
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
April 25, 2024
Tickers
ABBV
NEWS
REGN
SNY
Tags
General
Briefs
REGN
From
Benzinga
2 Small-Cap Growth Stocks With Room To Run
April 24, 2024
Tickers
ACHR
OCUL
REGN
RHHBY
Tags
RHHBY
REGN
OCUL
From
Motley Fool
Market Analysis: Regeneron Pharmaceuticals And Competitors In Biotechnology Industry
April 18, 2024
Tickers
NEWS
REGN
Tags
News
REGN
Trading Ideas
From
Benzinga
Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick
April 17, 2024
Tickers
AMGN
AZN
NEWS
REGN
Tags
Reiteration
Trading Ideas
Health Care
From
Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $6,700 Today
April 17, 2024
Tickers
NEWS
REGN
Tags
BZI/POD
Market News
News
From
Benzinga
Breaking Down Regeneron Pharmaceuticals: 13 Analysts Share Their Views
April 12, 2024
Tickers
REGN
Tags
BZI/AAR
Analyst Ratings
REGN
From
Benzinga
Eye Drug Eylea Price Manipulation: Regeneron Faces US Justice Department Allegations Over Medicare Pricing Of Its Best-Selling Eye Drug
April 11, 2024
Tickers
NEWS
REGN
Tags
General
Legal
REGN
From
Benzinga
Regeneron Pharmaceuticals's Options: A Look at What the Big Money is Thinking
April 11, 2024
Tickers
REGN
Tags
REGN
BZI/UOA
Benzinga
From
Benzinga
Should You Sell This Stock Following a Regulatory Roadblock?
April 05, 2024
Tickers
REGN
Tags
REGN
Market News
Recent Press Releases
From
Motley Fool
5 Healthcare Stocks to Buy for 2024
April 02, 2024
Tickers
AMGN
CRBP
ELEV
GILD
Tags
REGN
Stocks to Buy
XBI
From
InvestorPlace
Here's How Much $100 Invested In Regeneron Pharmaceuticals 10 Years Ago Would Be Worth Today
April 01, 2024
Tickers
NEWS
REGN
Tags
BZI/POD
Market News
REGN
From
Benzinga
Behind the Scenes of Regeneron Pharmaceuticals's Latest Options Trends
March 28, 2024
Tickers
REGN
Tags
REGN
BZI/UOA
Options
From
Benzinga
Stock-Split Watch: Are These 2 Top Growth Stocks Next?
March 28, 2024
Tickers
LLY
REGN
Tags
LLY
Market News
Recent Press Releases
From
Motley Fool
Decoding 12 Analyst Evaluations For Regeneron Pharmaceuticals
March 26, 2024
Tickers
REGN
Tags
Market News
Benzinga
Analyst Ratings
From
Benzinga
3 Biotech Stocks to Buy for the Next Bull Run: March 2024
March 26, 2024
Tickers
BNTX
REGN
VRTX
Tags
Market News
BNTX
VRTX
From
InvestorPlace
FDA Delays Decision For Regeneron's Inaugural Blood Cancer Therapy, Highlights Trial Concerns
March 25, 2024
Tickers
NEWS
REGN
Tags
Market News
Large Cap
News
From
Benzinga
Hot Stocks: The 3 Best Opportunities for Investing in Weight Loss Drugs
March 22, 2024
Tickers
LLY
REGN
RHHBY
Tags
LLY
NYSE:LLY,NASDAQ:REGN,OTCMKTS:RHHBY
REGN
From
InvestorPlace
Regeneron Pharmaceuticals Unusual Options Activity For March 20
March 20, 2024
Tickers
REGN
Tags
BZI/UOA
REGN
Market News
From
Benzinga
Unpacking the Latest Options Trading Trends in Regeneron Pharmaceuticals
March 15, 2024
Tickers
REGN
Tags
REGN
BZI/UOA
Markets
From
Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in March 2024
March 13, 2024
Tickers
PDSB
PFE
REGN
Tags
NYSE:PFE,NASDAQ:REGN,NASDAQ:PDSB
Market News
Stocks to Buy
From
InvestorPlace
NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
March 13, 2024
Tickers
BA
BRO
KSS
LUV
Tags
Markets
NVDA
BA
From
Benzinga
Active Growth ETF FDG Among Top 10 Mature Performers Over Last Year
March 12, 2024
Tickers
CMG
FDG
NVDA
REGN
Tags
NVDA
CMG
FDG
From
ETF Trends
Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon.
March 09, 2024
Tickers
MDGL
REGN
VRTX
Tags
Recent Press Releases
Market News
VRTX
From
Motley Fool
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
March 08, 2024
Tickers
NEWS
REGN
Tags
BZI/POD
Market News
News
From
Benzinga
2 Biotech Stocks to Buy Hand Over Fist in March
March 08, 2024
Tickers
EXEL
REGN
Tags
EXEL
REGN
Market News
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.